Health
Why Moderna Stock Climbed Today – Motley Fool
One analyst sees gains of nearly 40% ahead for the biotech’s shareholders.
What happened
Shares of Moderna (NASDAQ:MRNA) rose 6.8% on Friday, as analysts and investors grew more optimistic about the vaccine maker’s growth prospects.
So what
Piper Sandler analyst Edward Tenthoff repeated his overweight rating on Moderna’s stock and boosted his price forecast from $208 to $234 on Thursday. His new price target represents potential returns to shareholders of roughly 37% from Moderna’s current share price near $170.
Moderna’s stock price is up sharply in recent days. Image…
-
Noosa News24 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Business22 hours ago3 steps to take to build a $1,000 monthly passive income
-
Noosa News24 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
General18 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats